» Articles » PMID: 20553371

Neuroimaging, Gut Peptides and Obesity: Novel Studies of the Neurobiology of Appetite

Overview
Specialty Endocrinology
Date 2010 Jun 18
PMID 20553371
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Two major biological players in the regulation of body weight are the gut and the brain. Peptides released from the gut convey information about energy needs to areas of the brain involved in homeostatic control of food intake. There is emerging evidence that human food intake is also under the control of cortical and subcortical areas related to reward and cognition. The extent to which gut hormones influence these brain areas is not fully understood. Novel methods combining the study of neural activity and hormonal signalling promise to advance our understanding of gut-brain interactions. Here, we review a growing number of animal and human studies using neuroimaging methods (functional magnetic resonance imaging, positron emission tomography) to measure brain activation in relation to nutrient loads and infusion of gut peptides. Implications for current and future pharmacological treatments for obesity are discussed.

Citing Articles

The historical progression of positron emission tomography research in neuroendocrinology.

Bini J Front Neuroendocrinol. 2023; 70:101081.

PMID: 37423505 PMC: 10530506. DOI: 10.1016/j.yfrne.2023.101081.


Mapping brain activity of gut-brain signaling to appetite and satiety in healthy adults: A systematic review and functional neuroimaging meta-analysis.

Althubeati S, Avery A, Tench C, Lobo D, Salter A, Eldeghaidy S Neurosci Biobehav Rev. 2022; 136:104603.

PMID: 35276299 PMC: 9096878. DOI: 10.1016/j.neubiorev.2022.104603.


Psychopathological Syndromes Across Affective and Psychotic Disorders Correlate With Gray Matter Volumes.

Stein F, Meller T, Brosch K, Schmitt S, Ringwald K, Pfarr J Schizophr Bull. 2021; 47(6):1740-1750.

PMID: 33860786 PMC: 8530386. DOI: 10.1093/schbul/sbab037.


Comparison of surgical versus diet-induced weight loss on appetite regulation and metabolic health outcomes.

Halliday T, Polsky S, Schoen J, Legget K, Tregellas J, Williamson K Physiol Rep. 2019; 7(7):e14048.

PMID: 30927343 PMC: 6440915. DOI: 10.14814/phy2.14048.


Chimeric peptide EP45 as a dual agonist at GLP-1 and NPY2R receptors.

Chepurny O, Bonaccorso R, Leech C, Wollert T, Langford G, Schwede F Sci Rep. 2018; 8(1):3749.

PMID: 29491394 PMC: 5830615. DOI: 10.1038/s41598-018-22106-1.


References
1.
Stricker-Krongrad A, Dimitrov T, Beck B . Central and peripheral dysregulation of melanin-concentrating hormone in obese Zucker rats. Brain Res Mol Brain Res. 2001; 92(1-2):43-8. DOI: 10.1016/s0169-328x(01)00130-9. View

2.
Matsuda M, Liu Y, Mahankali S, Pu Y, Mahankali A, Wang J . Altered hypothalamic function in response to glucose ingestion in obese humans. Diabetes. 1999; 48(9):1801-6. DOI: 10.2337/diabetes.48.9.1801. View

3.
Chaudhri O, Parkinson J, Kuo Y, Druce M, Herlihy A, Bell J . Differential hypothalamic neuronal activation following peripheral injection of GLP-1 and oxyntomodulin in mice detected by manganese-enhanced magnetic resonance imaging. Biochem Biophys Res Commun. 2006; 350(2):298-306. DOI: 10.1016/j.bbrc.2006.09.033. View

4.
Thanos P, Michaelides M, Gispert J, Pascau J, Soto-Montenegro M, Desco M . Differences in response to food stimuli in a rat model of obesity: in-vivo assessment of brain glucose metabolism. Int J Obes (Lond). 2008; 32(7):1171-9. PMC: 2667112. DOI: 10.1038/ijo.2008.50. View

5.
Baile C, McLaughlin C, Della-Fera M . Role of cholecystokinin and opioid peptides in control of food intake. Physiol Rev. 1986; 66(1):172-234. DOI: 10.1152/physrev.1986.66.1.172. View